Table 1. Patient Demographics and Baseline Characteristics in the ITT population.
| Parameter: | ST (N = 39) | IM (N = 41) | Total (N = 80) |
| Age (years) | |||
| Mean (SD) | 37.7 (8.51) | 39.9 (9.89) | 38.9 (9.25) |
| Median (Range) | 37.0 (24.0 – 59.0) | 39.0 (23.0 – 75.0) | 38.0 (23.0 – 75.0) |
| Gender | |||
| Male; N (%) | 36 (92.3%) | 31 (75.6%) | 67 (83.8%) |
| Race: N (%) | |||
| Caucasian | 36 (92.3%) | 39 (95.1%) | 75 (93.8%) |
| American Indian/Alaska Native | 3 (7.7%) | 2 (4.9%) | 5 (6.2%) |
| Disease duration 2(years) | |||
| N | 26 | 27 | 53 |
| Mean (SD) | 3.4 (3.85) | 3.1 (2.00) | 3.3 (3.02) |
| Absolute CD4+ T-cell count (cell/mm3) | |||
| N | 39 | 41 | 80 |
| Mean (SD) | 401.2 (222.5) | 364.6 (164.3) | 382.5 (194.5) |
| Viral load (log10 RNA copies/mL) | |||
| N | 39 | 41 | 80 |
| Mean (SD) | 1.689 (0.063) | 1.680 (0.087) | 1.684 (0.076) |